RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined...
Transcript of RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined...
![Page 1: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/1.jpg)
RADIOTHERAPY
FOR
PEDIATRIC HODGKIN’S LYMPHOMA
![Page 2: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/2.jpg)
Region Cases per 100,000 children
United States 0.5
European Union 0.58
Latin America 1.0-1.5
Greece 0.78
India 0.42
GLOBAL INCIDENCE
** Approx. 6% of all childhood cancers
![Page 3: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/3.jpg)
BIMODAL AGE PEAK
* EBV Virus Associated
* Mixed Cellularity Subtype
![Page 4: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/4.jpg)
Ind. Pediatrics 2006; 43 (141-147)
![Page 5: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/5.jpg)
THOMAS HODGKIN
“1832”
“On Some Morbid Appearances of the
Absorbent Glands & Spleen”
![Page 6: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/6.jpg)
1960’s Development of the MOPP regimen
Appreciation of adverse effects of “High Dose Radiation”
Investigation of “Combined Modality Therapy”
1970’s & 80’s
Development of better imaging facilities (CT scan)
Diminished importance of staging laparotomy
GHSG HD 78 – all pts lap staged
GHSG HD 82 – all lap staged, splenectomy only if visible
abnormalities at lap
GHSG HD 85 – lap staging only if abnormal USG/ CT scan
GHSG HD 90 – laparotomy abandoned
Risks of Infertility / Leukemogenesis – Alkylating agents
Development of ABVD regimen
Development of MOPP/ ABVD hybrid regimen
Reduction in doses of radiotherapy when used with chemo
![Page 7: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/7.jpg)
The 90’s
Recognition of the need to optimize therapy (Chemo & RT)
Recognition of prognostic groups
Early Stage Favourable
Early Stage Unfavourable
Advanced Stage Disease
Development of risk adapted therapy
Development of response adapted therapy
![Page 8: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/8.jpg)
IMROVEMENT IN SURVIVAL
![Page 9: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/9.jpg)
RISK FACTORS & TREATMENT GROUPS
Early Stage Risk Factor Treatment Group
EORTC Bulky Mediast. Mass
Age ≥ 50 yrs
Elevated ESR
B Symptoms
≥ 4 nodal regions
Fav: St. I-II without risk factors
Unfav: St. I-II with risk factors
GHSG Bulky Medist. Mass
Elevated ESR
B Symptoms
≥ 3 nodal regions
Fav: St. I-II without risk factors
Intermed: St. I-IIA with risk
factors
Unfav: St. IIB with Elevated
ESR
ECOG & NCI-C Histology (MC, LD)
Age ≥ 40 yrs
Elevated ESR
B Symptoms
≥ 4 nodal regions
Fav: St. I-II without risk factors
Unfav: St. I-II with risk factors
Advanced Stage
International Prognostic Score Serum Albumin ≤ 4 g/dl
Hemoglobin ≤ 10.5 g/dl
Male
Age ≥ 45 yrs
WBC Count ≥ 15 thousand
Lymphocyte Count ≤8% of
WBC
![Page 10: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/10.jpg)
RISK GROUPS FOR PEDS HD
![Page 11: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/11.jpg)
DOES RADIATION WORK ?
Vera Peters (1950): The first physician to present definitive
evidence of curability of Hodgkin’s disease.
Reviewed the records 113 patients treated at the Ontario Institute
of Radiotherapy from 1924 – 1942 and reported 10 year survival
rates of 79% for stage I Hodgkin’s disease using high dose
fractionated extended field radiation therapy
Am J Roentgenol 1950; 63: 299-311.
![Page 12: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/12.jpg)
INRT (Involved Nodal RT)
IFRT
Mini Mantle
Mantle
Extended Mantle
Inverted “Y”
Hemi Inverted “Y”
Spade Field
Subtotal Nodal Irradiation
Total Nodal Irradiation
![Page 13: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/13.jpg)
COMBINED MODALITY FOR EARLY STAGE FAVOURABLE
![Page 14: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/14.jpg)
COMBINED MODALITY FOR ADVANCED STAGE
![Page 15: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/15.jpg)
COMBINED MODALITY TREATMENT
![Page 16: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/16.jpg)
RECENT COMBINED MODALITY STUDIES
![Page 17: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/17.jpg)
![Page 18: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/18.jpg)
INFERENCES
• Combined Chemotherapy & Radiation Therapy – Excellent Outcome
• Risk Stratified Treatment – Low vs. Intermediate vs. High
• Need to have an optimal combination of CTh & RT
![Page 19: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/19.jpg)
CAN WE AVOID CHEMOTHERAPY FOR EARLY STAGE
FAVOURABLE DISEASE ?
![Page 20: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/20.jpg)
JCO August 2007
RT Alone: 67%
CTh + RT: 88%
![Page 21: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/21.jpg)
CAN WE AVIOD RADIATION AFTER MULTIAGENT CHEMO ?
![Page 22: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/22.jpg)
3 Year EFS CTh Alone: 85%
3 Year EFS CTh + RT: 93%, p=0.0024
![Page 23: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/23.jpg)
IJROBP 2001
• DFS & PFS superior with adjuvant RT
• RT dose could be reduced safely to 20Gy
• Exploring feasibility of avoiding RT in St I & IIA in CR
![Page 24: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/24.jpg)
![Page 25: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/25.jpg)
Inferences from our study on “Consolidation RT after CR”
a) 179/251 (71%) achieved CR after 6 cycles of ABVD
b) Pts. with Bulky disease / Young Age / Mediastinal Disease had superior
outcomes with adjuvant IFRT
![Page 26: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/26.jpg)
![Page 27: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/27.jpg)
WHAT IS THE OPTIMAL RADIATION VOLUME ?
![Page 28: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/28.jpg)
MANTLE FIELD FOR TREATMENT OF
SUPRADIAPHRAGMATIC NODAL REGIONS
RT DOSE: 15-30Gy
![Page 29: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/29.jpg)
INVERTED “Y” FIELD
FOR TREATMENT OF
INFRADIPHRAGMATIC
NODAL REGIONS
![Page 30: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/30.jpg)
![Page 31: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/31.jpg)
![Page 32: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/32.jpg)
BASIC RULES
• Examination of patient by Radiation Oncologist.
• Pre and Post chemotherapy CT and FDG-PET scan performed in the treatment position.
• Scans should encompass cervical, axillary, and mediastinal areas.
• Remission status – For each initially involved lymph node should be determined exclusively on CT scans.
• Modern Radiation techniques
- Immobilization.
- CT simulation.
- Fusion techniques.
- 3D-CRT.
- Intensity modulated Radiotherapy.
- Respiratory Gated Radiotherapy.
![Page 33: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/33.jpg)
WHAT IS THE OPTIMAL RADIATION DOSE ?
![Page 34: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/34.jpg)
JCO July 2007
![Page 35: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/35.jpg)
![Page 36: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/36.jpg)
IJROBP 2003
![Page 37: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/37.jpg)
IJROBP 2001
![Page 38: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/38.jpg)
JCO 2005
![Page 39: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/39.jpg)
LATE EFFECTS OF HODGKIN’S DISEASE TREATMENT
Musculoskeletal abnormalities
Pulmonary Sequelae
Cardiovascular Sequelae
Thyroid dysfunction
Second Malignancies
Leukemogenesis
NHL
Solid Tumors
![Page 40: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/40.jpg)
CARDIOVASCULAR LATE EFFECTS
STANFORD
(1960-1995)
2498 Pts. 754 Deaths 16%
CV disease
JCRT
(1969-1996)
794 Pts. 124 Deaths 14%
CV disease
EORTC
(1963-1986)
1449 Pts. 240 Deaths 7%
CV disease
BNLI 1043 Pts. 43 Deaths 14%
CV disease
Decreasing CV deaths with improving therapy (CT & RT)
Stage I & II at Stanford (CV deaths after 15yrs of treatment)
1962 - 1980: 812 pts. ------ 5.4%
1980 – 1996: 628 pts. ------ 0.8%
![Page 41: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/41.jpg)
HODGKIN’S DISEASE CURRENT GUIDELINES
Early Stage Favourable (Low Risk)
Multiagent CTh x 2 - 4 cycles + IFRT
Early Stage Unfavourable (Intermediate Risk)
Multiagent CTh x 4 cycles + IFRT
Advanced Stage (High Risk)
Multiagent CTh x 6-8 cycles ± IFRT
![Page 42: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/42.jpg)
INDICATIONS FOR ADJUVANT RADIATION THERAPY
Early Stage Disease as part of combined CT + RT
Bulky Disease at Presentation (Irrespective of Response to CT)
Residual Disease/ Partial Response after Chemotherapy
![Page 43: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/43.jpg)
Microscopic: 14.4 – 19.80 Gy/8 - 11#/ 2 - 3wks @ 1.8Gy / fr.
Gross: 25.2 – 30.6Gy/14 - 17#/ 3 - 4wks @ 1.8Gy / fr.
RADIATION DOSE
![Page 44: RADIOTHERAPY FOR · 2012-11-19 · Radiation therapy remains an integral part of the combined modality Management of Pediatric Hodgkin’s Lymphoma Chemotherapy combined with Low](https://reader033.fdocuments.in/reader033/viewer/2022060514/5f86dae9136629048d7f6bbf/html5/thumbnails/44.jpg)
SUMMARY & CONCLUSIONS
Radiation therapy remains an integral part of the combined modality
Management of Pediatric Hodgkin’s Lymphoma
Chemotherapy combined with Low dose IFRT results in optimal outcome
In early stage disease
Adjuvant IFRT improved local control inpatients with bulky disease at
presentation or patients with residual disease after CTh
Currently applicable radiation volumes & doses result in minimal
adverse effects